Topics

STAT Plus: Pharmalittle: Tension in the Verily-Dexcom tango; not so fast on the Pfizer-GSK spinoff

09:41 EST 16 Jan 2020 | STAT

GlaxoSmithKline hasn’t made plans to pursue an IPO of the consumer-health company it set up with Pfizer, a top executive said, distancing himself from remarks made by Pfizer’s chief executive a…

Original Article: STAT Plus: Pharmalittle: Tension in the Verily-Dexcom tango; not so fast on the Pfizer-GSK spinoff

NEXT ARTICLE

More From BioPortfolio on "STAT Plus: Pharmalittle: Tension in the Verily-Dexcom tango; not so fast on the Pfizer-GSK spinoff"

Quick Search

Relevant Topics

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...